Prenatal Testing Market in the US 2014-2018

Prenatal Testing Market in the US 2014-2018

Category : Diagnostic and Biotech
Published On : January  2014
Pages : 54

------------ Or -------------

TechNavio's analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. 
TechNavio's report, the Prenatal Testing Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the US; it also covers the Prenatal Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc.
Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc. 
Key questions answered in this report: 
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
07.1 Prenatal Testing Market in the US by Technology
07.1.1 Invasive Prenatal Testing
07.1.2 Non-invasive Prenatal Testing
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors
16. Key Vendor Analysis
16.1 PerkinElmer Inc.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Quest Diagnostics Inc.
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Sequenom Inc.
16.3.1 Business Overview
16.3.2 Business Segmentation
16.3.3 Key Information
16.3.4 SWOT Analysis
16.4 Verinata Health Inc.
16.4.1 Business Overview
16.4.2 Key Information
16.4.3 SWOT Analysis
17. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Prenatal Testing Market in the US Overview
Exhibit 3: Prenatal Testing Market in the US 2013-2018 (US$ billion)
Exhibit 4: Prenatal Testing Market in the US Segmentation by Technology
Exhibit 5: Prenatal Testing Market in the US Segmentation 2013
Exhibit 6: Global Incidence of Chromosomal Abnormalities in Newborns
Exhibit 7: Business Segmentation of PerkinElmer Inc.
Exhibit 8: Business Segmentation of Quest Diagnostics Inc.
Exhibit 9: Business Segmentation of Sequenom Inc.

Enquiry Before Buy